| Financial Year |
March 31 2022 |
| Monetary Funds |
3,299,617,360.92 |
| Held-for-trading Financial Assets |
1,243,163,643.31 |
| Notes Receivable |
1,650,000.00 |
| Accounts Receivable |
2,731,857,383.97 |
| Advances to Suppliers |
209,637,594.58 |
| Other Receivables |
29,010,305.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,797,129,387.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
325,273,516.36 |
| Total Current Assets |
10,203,699,718.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
136,385,895.27 |
| Long-term Equity Investment |
238,000,000.00 |
| Investment Properties |
43,391,328.35 |
| Fixed Assetes |
9,535,876,787.78 |
| Under-construction Projects |
932,918,880.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
235,769,442.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,004,006.27 |
| Deferred Income Tax Assets |
185,178,462.93 |
| Other Non-Current Assets |
202,098,650.84 |
| Sub-Total of Non-Current Assets |
11,979,025,569.06 |
| Total Assets |
22,182,725,287.39 |
| Short-Term Loans |
1,261,809,734.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
679,780,363.90 |
| Accounts Payable |
1,429,345,755.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,201,613.34 |
| Taxes Payable |
74,680,895.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
199,580,598.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,165,586,077.04 |
| Other Current Liabilities |
60,927,464.54 |
| Sub-Total of Current Liabilities |
5,372,118,674.95 |
| Long-term Loans |
92,940,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,323,074,709.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
32,810,544.06 |
| Deferred Income Tax Liabilities |
5,452,650.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,934,937,807.73 |
| Total Liabilities |
11,307,056,482.68 |
| Paid-In Capital(Or Share Stock) |
2,414,602,861.00 |
| Capital Surplus |
4,920,819,110.87 |
| Surplus Reserve |
156,036,773.41 |
| LESS:Treasury Stock |
60,250,000.00 |
| Undistributed Profits |
3,375,472,474.45 |
| Minority Stockholder's Interest |
68,987,584.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,806,681,219.73 |
| Owner's Equity（Stockholder's Equity） |
10,875,668,804.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,182,725,287.39 |
